Recent & Upcoming Talks

We are hosting a new meeting we are hosting on research into Lymphoid Malignancies with Interdisciplinary Techniques (LyMIT), which will take place on the 6th September 2022.

We are excited to share that the Mitchell Lab have had two abstracts accepted for the European Haematology Associations annual congress, EHA2022, June 9th-12th 2022.

The Mitchell group are participating the European School of Haematology’s 6th Translational Research Conference on Lymphoid Malignancies (ESH Lymphoid 2021) (Oct 14-17 2021). A number of our members presenting research updates, which are available to view now!

Dr Mitchell was recently awarded a prestigious £1.2m UKRI Future Leaders Fellowship to tackle Relapsed/Refractory DLBCL with Systems Biology approaches. The UKRI Future Leaders scheme invests in early career researchers and innovators with outstanding potential, helping them to develop their careers while tackling ambitious challenges.

Simon has been invited to present at the European Haematology Associations annual congress, June 9th-17th 2021. Simon will present his progress in understanding diffuse large B-cell lymphoma through systems biology. His presentation “A SYSTEMS BIOLOGY APPROACH TO DLBCL PREDICTS EMERGENT PHENOTYPES FROM MOLECULAR DYSREGULATION AND IDENTIFIES DISTINCT ROLES FOR NF-KB SUBUNITS CREL AND RELA.

The entire Mitchell group will be participating in SMB 2021 (June 13-17, 2021) with a number of members presenting research updates. Ielyaas Cloete will present his progress in simulating apoptotic signaling networks to enable better understanding their role in B-Cell lymphoma.

Dr Mitchell was recently interviewed about his Leukaemia UK John Goldman Fellowship.